Vascular endothelial growth factor (VEGF) -A, -C and VE-cadherin as potential biomarkers in early breast cancer patients.
- DOI
- 10.1016/j.prp.2023.154923
- Published
- 2023 Dec
- Container
- Pathology, research and practice
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.prp.2023.154923,
title = {Vascular endothelial growth factor (VEGF) -A, -C and VE-cadherin as potential biomarkers in early breast cancer patients.},
author = {Milovanović J and Vujasinović T and Todorović-Raković N and Greenman J and Hranisavljević J and Radulovic M},
year = {2023},
journal = {Pathology, research and practice},
doi = {10.1016/j.prp.2023.154923},
url = {https://doi.org/10.1016/j.prp.2023.154923}
}RIS
TY - JOUR TI - Vascular endothelial growth factor (VEGF) -A, -C and VE-cadherin as potential biomarkers in early breast cancer patients. AU - Milovanović J AU - Vujasinović T AU - Todorović-Raković N AU - Greenman J AU - Hranisavljević J AU - Radulovic M PY - 2023 JO - Pathology, research and practice DO - 10.1016/j.prp.2023.154923 UR - https://doi.org/10.1016/j.prp.2023.154923 ER -
APA
J, M., T, V., N, T., J, G., J, H., & M, R. (2023). Vascular endothelial growth factor (VEGF) -A, -C and VE-cadherin as potential biomarkers in early breast cancer patients.. Pathology, research and practice. https://doi.org/10.1016/j.prp.2023.154923
Source records
- pubmed · retrieved 2026-09-27T09:41:31.961Z